Filter by: patients
Home > Community Treatment Reports and Side Effects > Rituximab Treatment Report
What is Rituximab?

Rituximab is an injectable drug that is in a class of medications called monoclonal antibiodies. It is used in the treatment of non-Hodgkins lymphoma and also in the treatment of rheumatoid arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Neuromyelitis Optica 30 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
MS (Multiple Sclerosis) 25 12 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Other 17 3 Efficacy_moderate Efficacy_slight
RA (Rheumatoid Arthritis) 15 4 Efficacy_major Efficacy_cant_tell
Systemic Lupus Erythematosus 5 1 Efficacy_major
Rheumatoid Arthritis 3 2 Efficacy_major Efficacy_moderate

See all 72 patients currently taking Rituximab

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 6
Moderate
 3
Mild
 15
None
 17

Commonly reported side effects, conditions, and hospitalizations associated with Rituximab

Allergic reaction 4
Fatigue 3
Hospitalization 2
Flu like symptoms 2
Migraine headaches 2
Respiratory infections 2
See all 28 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Rituximab. See all 42 dosages ►

  500mg as needed 10mg/mL as needed 1,000mg as needed 1g as needed 1 other yearly 10 mg yearly 10 mg every 3 months 1,000 mg yearly 1,000 mg every 3 months 1,000 mg every other week
  2 Number of Patients: 2 8 Number of Patients: 8 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 5 Number of Patients: 5 8 Number of Patients: 8 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Rituximab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 25   Course of treatment ended: 41%
Did not seem to work 13   Did not seem to work: 21%
Doctor's advice 12   Doctor's advice: 20%
Side effects too severe 11   Side effects too severe: 18%
Not indicated 8   Not indicated: 13%
Other 8   Other: 13%
Expense 2   Expense: 3%
Change in health plan coverage 1   Change in health plan coverage: 2%

See all 59 patients who’ve stopped taking Rituximab

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Rituximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Rituximab

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Rituximab

Always
 35 85%
Usually
 1 2%
Sometimes
 2 5%
Never
 3 7%

Burden

Difficulty being on treatment

Burden of Rituximab

Very
 3 7%
Somewhat
 14 34%
A little
 13 32%
Not at all
 11 27%

Cost

Paid out of pocket

Cost of Rituximab

$200+
 8 32%
$100-199
 3 12%
$50-99
 0 0%
$25-49
 1 4%
< $25
 12 48%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 28, 2012.